Your Article Summary
Prestwick Pharmaceuticals Appoints George F. Horner III as President and Chief Executive Officer
Corporate News Releases - The Healthcare Sales & Marketing Network, 08/23/06
Prestwick Pharmaceuticals, Inc., a privately-held biotechnology company focused on developing and commercializing novel treatments for chronic diseases of the central nervous system, announced that George F. Horner III has been appointed president and chief executive officer
Today in Execs on the Move...keeping you current
Receive free subspecialty "5-minute updates" via email
Thomas H. Silberg to Retire as President and CEO of APP Pharmaceuticals, John Ducker Named as Successor
American Pharmaceutical Partners, 12/03/09
Cardinal Health names Carrie Cox to board of directors
Cardinal Health, 12/03/09
Medtronic Names Michael J. Coyle as Executive Vice President and Group President of Cardiology Businesses
Medtronic, 12/03/09
Article Search
Sponsor


See Latest Articles


